Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ambu presented 2019/20 financial guidance and product updates including aScope Cysto and aView 2 Advance launches, with aScope Duodeno pending FDA approval. The company upgraded full-year guidance and announced accelerated commercial infrastructure investments of DKK 115m to support new product rollouts.
annual_report
20 Pages
investor_presentation
39 Pages
Waitr Incorporated
Albaraka Türk Q1 2024 Investor Presentation
investor_presentationinvestor_presentation
20 Pages
Albaraka Türk Participation Bank
